News from Fermion

New regulatory files for hydroxychloroquine and sodium cromoglicate are now available

USDMF for Fermion’s hydroxychloroquine sulphate is now available for reference... (8 April 2016)

API manufacturing facility expansion, Hanko, Finland

2018 will mark the start of a new era in Fermion’s history as Fermion’s plant... (15 March 2016)

Successful ANVISA Inspection at Fermion's API manufacturing plant in Oulu, Finland

Fermion passed successfully ANVISA Inspection 2016 with three minor... (4 February 2016)

Thought leadership articles

Benefits of outsourcing to sponsor companies and pharmaceutical lifecycle... (17 December 2015)

Autumn news from Fermion: expansion of the bench scale unit and HPAPI production update

The past 6 months have been a busy time for Fermion. We have successfully... (1 September 2015)

FERMION

  • Manufacturer of Active Pharmaceutical Ingredients (API) for both generic and proprietary drug products since 1970.
  • Contract manufacturing services for APIs including oncology and highly potent compounds.

Meet us at: